ALTAMURA, CLAUDIA
 Distribuzione geografica
Continente #
AS - Asia 6.878
NA - Nord America 1.728
EU - Europa 958
SA - Sud America 530
AF - Africa 49
OC - Oceania 13
AN - Antartide 1
Totale 10.157
Nazione #
SG - Singapore 5.315
US - Stati Uniti d'America 1.665
CN - Cina 659
HK - Hong Kong 458
IT - Italia 440
BR - Brasile 407
VN - Vietnam 216
GB - Regno Unito 131
FR - Francia 116
DE - Germania 88
IN - India 56
AR - Argentina 52
ID - Indonesia 33
CA - Canada 29
EC - Ecuador 26
NL - Olanda 26
BD - Bangladesh 23
EE - Estonia 22
FI - Finlandia 21
MX - Messico 18
TR - Turchia 17
RU - Federazione Russa 16
AT - Austria 15
UA - Ucraina 15
ZA - Sudafrica 15
IQ - Iraq 13
JP - Giappone 13
AU - Australia 12
CO - Colombia 11
PH - Filippine 11
ES - Italia 10
SA - Arabia Saudita 10
SE - Svezia 10
PK - Pakistan 9
CZ - Repubblica Ceca 8
MA - Marocco 8
PL - Polonia 8
CL - Cile 7
PE - Perù 7
PY - Paraguay 7
VE - Venezuela 7
MY - Malesia 6
DZ - Algeria 5
HR - Croazia 5
KZ - Kazakistan 5
TN - Tunisia 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
LT - Lituania 4
NP - Nepal 4
AL - Albania 3
BE - Belgio 3
BO - Bolivia 3
EG - Egitto 3
GE - Georgia 3
GR - Grecia 3
KR - Corea 3
PT - Portogallo 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
MT - Malta 2
OM - Oman 2
PS - Palestinian Territory 2
RO - Romania 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GY - Guiana 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MS - Montserrat 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SO - Somalia 1
YT - Mayotte 1
Totale 10.157
Città #
San Jose 672
Hong Kong 452
Singapore 431
Ashburn 382
Rome 289
Hefei 237
Beijing 160
Dallas 121
Boardman 113
London 105
Lauterbourg 102
Shanghai 80
Ho Chi Minh City 76
Hanoi 53
São Paulo 43
Munich 29
Santa Clara 29
Los Angeles 26
San Francisco 26
Council Bluffs 22
Sona 22
Pune 18
New York 15
Amsterdam 14
Nuremberg 13
Seattle 13
Frankfurt am Main 11
Milan 11
Washington 11
Helsinki 10
Montreal 10
Quito 10
Rio de Janeiro 10
Tokyo 10
Toronto 10
West Jordan 10
Chennai 9
Florence 9
Guayaquil 9
Redmond 9
Turku 9
Brasília 8
Stockholm 8
Warsaw 8
Baghdad 7
Joinville 7
Porto Alegre 7
Brno 6
Haiphong 6
Mexico City 6
Boston 5
Can Tho 5
Dhaka 5
Edinburgh 5
Istrana 5
Johannesburg 5
Lima 5
Manaus 5
Manchester 5
Melbourne 5
Quảng Ngãi 5
Santa Fe 5
Tashkent 5
Vienna 5
Bologna 4
Brooklyn 4
Buenos Aires 4
Caxias do Sul 4
Chicago 4
Da Nang 4
Delhi 4
Feira de Santana 4
Ha Long 4
Hortolândia 4
Jeddah 4
Kathmandu 4
Miami 4
Ninh Bình 4
Niterói 4
Osasco 4
Phoenix 4
Riyadh 4
Salvador 4
Sydney 4
Tunis 4
Turin 4
Vũng Tàu 4
Asunción 3
Athens 3
Bắc Giang 3
Caivano 3
Central 3
Centro 3
Charlotte 3
Cuenca 3
Curitiba 3
Dakar 3
Fiesole 3
Hải Dương 3
Jakarta 3
Totale 3.955
Nome #
1-Hz repetitive transcranial magnetic stimulation increases cerebral vasomotor reactivity: a possible autonomic nervous system modulation 388
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 246
Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: A correlation study in patients with cognitive impairment 245
Psychopathological variables in chronic migraine patients with different therapeutic approach: psychological profile differences and impact on therapeutic efficacy in real life 226
Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment 223
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 223
Task-switching abilities in episodic and chronic migraine 223
Acute Carotid Dissection in an Adult Caused by Pertussis 219
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study 217
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project 214
Correction to: Task-switching abilities in episodic and chronic migraine (Neurological Sciences, (2022), 10.1007/s10072-021-05837-4) 212
Stroke territory and atherosclerosis in ischemic stroke patients with a history of migraine with aura 201
Cerebral Hemodynamics, Right-to-Left Shunt and White Matter Hyperintensities in Patients with Migraine with Aura, Young Stroke Patients and Controls 199
Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection - A Narrative Review 197
Cerebral distribution of white matter lesions in migraine with aura patients 196
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 196
CAROTID WALL THICKNESS AND STROKE RISK IN PATIENTS WITH ASYMPTOMATIC INTERNAL CAROTID STENOSIS 193
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment 187
Cerebral vasomotor reactivity in the acute phase and after 6 months in non-disabling stroke/TIA: A prospective cohort study 186
Right-to-Left Shunt and the Clinical Features of Migraine with Aura: Earlier but Not More 181
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 144
Frequency and clinical implications of hypercoagulability states in a cohort of patients with migraine with aura 141
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 133
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study 129
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 117
Relationship among diffusion tensor imaging, EEG activity, and cognitive status in mild cognitive impairment and Alzheimer's disease patients 113
Carotid Artery Plaque Progression: Proposal of a New Predictive Score and Role of Carotid Intima-Media Thickness 113
Gepants - a long way to cure: a narrative review 111
Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia 111
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 111
Acute medications' intake for migraine: a one-year report in patients undergoing first evaluation at a third level Italian headache center 110
Embodying an artificial hand increases blood flow to the investigated limb [version 3; peer review: 2 approved] 109
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study 107
Bilateral MCP Infarct Due to Vertebral Giant Cell Arteritis 107
Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia 103
Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease 101
Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease 101
Cerebrovascular assessment for the risk prediction of Alzheimer's disease 100
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study 99
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairment 98
Ceruloplasmin/Transferrin system is related to clinical status in acute stroke 97
Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study 93
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 90
Patients with migraine with aura have increased flow mediated dilation 83
Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study 78
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 77
Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles-A Narrative Review 70
The role of endothelial dysfunction in the pathophysiology and cerebrovascular effects of migraine: A narrative review 65
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) 61
Vascular predictors of cognitive decline in patients with mild cognitive impairment 59
fMRI-vs-MEG evaluation of post-stroke interhemispheric asymmetries in primary sensorimotor hand areas 56
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 56
Erenumab does not alter cerebral hemodynamics and endothelial function in migraine without aura 54
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 54
Markers of lacunar stroke in patients with moderate internal carotid artery stenosis 53
Cognitive performance is related to ceruloplasmin/transferrin system in patients with chronic hepatitis 53
Cortical neuromodulation modifies cerebral vasomotor reactivity 52
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 52
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 51
Patent foramen ovale and migraine with aura in a retrospective analysis: age matters 51
Does cerebrovascular disease affect the coupling between neuronal activity and local haemodynamics? 51
Emerging Risk Factors for Dementia: The Role of Blood Pressure Variability 50
Pathophysiological Bases of Comorbidity in Migraine 50
Shorter visual aura characterizes young and middle-aged stroke patients with migraine with aura 50
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study 50
Thresholds of impaired cerebral hemodynamics that predict short-term cognitive decline in asymptomatic carotid stenosis 49
Gadolinium Enhancement in a Case of Uncomplicated Posterior Reversible Encephalopathy Syndrome 48
Cortical ischemic lesion burden measured by DIR is related to carotid artery disease severity 48
Internal jugular vein valve incompetence in transient global amnesia: more circumstantial evidence or the proof solving the mystery? 48
The evolving concept of multimorbidity and migraine 48
Markers for the risk of progression from mild cognitive impairment to Alzheimer's disease 47
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 46
Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study 46
High frequency repetitive transcranial magnetic stimulation decreases cerebral vasomotor reactivity 46
Serotonin depletion and barrel cortex development: impact of growth impairment vs. serotonin effects on thalamocortical endings 45
The Healthy Eating Plate Advice for Migraine Prevention: An Interventional Study 45
Dorsolateral medullary ischemic infarction causing autonomic dysfunction and headache: a case report 44
Ruolo delle mappe ADC nella diagnosi differenziale tra demenza vascolare e demenza di Alzheimer 44
When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway? 44
Ultrasonographic markers of vascular risk in patients with asymptomatic carotid stenosis 43
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men 43
The Role of White Matter Damage in the Risk of Periprocedural Diffusion-Weighted Lesions after Carotid Artery Stenting. 40
Neuroimaging experimental studies on brain plasticity in recovery from stroke 40
What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia? 40
Hypercapnia affects the functional coupling of resting state electroencephalographic rhythms and cerebral haemodynamics in healthy elderly subjects and in patients with amnestic mild cognitive impairment 40
Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience 39
Neuronal functionality assessed by magnetoencephalography is related to oxidative stress system in acute ischemic stroke 38
Right-to-left shunts and hormonal therapy influence cerebral vasomotor reactivity in patients with migraine with aura 37
Hemoglobin oxygen saturation as a marker of cerebral hemodynamics in carotid artery occlusion : An integrated transcranial doppler and near-infrared spectroscopy study 37
Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration 37
Early activation of intracranial collateral vessels influences the outcome of spontaneous internal carotid artery dissection 37
Excessive daytime sleepiness is associated to the development of swallowing impairment in a cohort of early stage drug naïve Parkinson's disease patients 37
Influence of chronotype on migraine characteristics 36
Cognitive deterioration in bilateral asymptomatic severe carotid stenosis 36
One-year progression of moderate asymptomatic carotid stenosis predicts the risk of vascular events 36
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study) 36
Transient global amnesia and jugular vein incompetence response 35
Daith Piercing in a Case of Chronic Migraine: A Possible Vagal Modulation 35
Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome 35
Lack of correlation between cerebral vasomotor reactivity and flow-mediated dilation in subjects without vascular disease 35
Totale 9.626
Categoria #
all - tutte 51.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.206


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022131 0 0 3 0 0 0 0 0 17 4 0 107
2022/202366 2 2 2 2 7 4 4 11 7 4 17 4
2023/2024348 17 40 12 31 36 144 5 27 6 10 9 11
2024/20255.796 43 44 123 11 14 68 106 62 322 411 2.235 2.357
2025/20263.852 371 258 339 588 177 218 1.084 235 345 237 0 0
Totale 10.193